BGLC (STOCKS)
BioNexus Gene Lab Corp Common stock
$2.230000
+0.080000 (+3.72%)
Prev close: $2.150000
Company Information
- Exchange
- XNAS
- Sector
- Distribution Services
- Industry
- Wholesale Distributors
- CEO
- Su Leng Tan Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.06M
- Employees
- 1
- P/E (TTM)
- -1.77
- P/B (TTM)
- 0.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $9.47M |
| Benefits Costs and Expenses | $11.84M |
| Cost Of Revenue | $8.07M |
| Costs And Expenses | $11.84M |
| Gross Profit | $1.40M |
| Operating Expenses | -$5.04M |
| Research and Development | $56.97K |
| Operating Income/Loss | -$2.35M |
| Income/Loss From Continuing Operations After Tax | -$2.29M |
| Income/Loss From Continuing Operations Before Tax | -$2.37M |
| Income Tax Expense/Benefit | -$80.70K |
| Net Income/Loss | -$1.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $3.20M |
| Net Income/Loss Attributable To Parent | -$2.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | -$976.63K |
| Diluted Earnings Per Share | -$0.47 |
| Diluted Average Shares | 17,838,314 |
| Assets | $7.62M |
| Current Assets | $5.63M |
| Inventory | $1.01M |
| Other Current Assets | $4.62M |
| Noncurrent Assets | $1.99M |
| Fixed Assets | $1.57M |
| Other Non-current Assets | $423.84K |
| Liabilities | $804.97K |
| Current Liabilities | $678.02K |
| Noncurrent Liabilities | $126.94K |
| Equity | $6.82M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.82M |
| Liabilities And Equity | $7.62M |
| Net Cash Flow From Operating Activities | -$2.72M |
| Net Cash Flow From Operating Activities, Continuing | -$2.72M |
| Net Cash Flow From Investing Activities | $1.50M |
| Net Cash Flow From Investing Activities, Continuing | $1.50M |
| Net Cash Flow From Financing Activities | $30.91K |
| Net Cash Flow From Financing Activities, Continuing | $30.91K |
| Exchange Gains/Losses | -$122.80K |
| Net Cash Flow | -$1.31M |
| Net Cash Flow, Continuing | -$1.19M |
| Comprehensive Income/Loss | -$2.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.57M |
| Other Comprehensive Income/Loss | -$4.17M |